Department of Neurosurgery, Koç University Hospital, Istanbul, Turkey.
Department of Neurosurgery, Gamma Knife Center, Koç University Hospital, Istanbul, Turkey.
Neurosurgery. 2023 Jul 1;93(1):102-111. doi: 10.1227/neu.0000000000002382. Epub 2023 Feb 1.
The management of craniopharyngiomas is challenging, usually requiring multidisciplinary care. Gamma Knife radiosurgery (GKRS) is an essential technique for residual/recurrent craniopharyngiomas.
To evaluate the efficacy of frameless hypofractionated GKRS (hfGKRS) for craniopharyngioma and factors which affect tumor control and complications.
This retrospective study involved 24 patients managed with hfGKRS. Clinical and radiological data, tumor characteristics, and procedural details were analyzed.
There were 15 (62.5%) female patients. The median age was 38.5 years (range, 3-66 years). The mean tumor volume was 2.4 (1.93) cm 3 , with a mean solid volume of 1.6 (1.75) cm 3 . The median marginal dose was 20 Gy (range, 18-25 Gy) delivered in a median of 5 fractions (range, 3-5). During a median radiological follow-up of 23.5 months (range, 12-50 months), tumor progression was noted in 5 (20.8%) patients. The 2-year and 4-year progression-free survival were 81.8% and 61.4%, respectively. No deaths were identified at a median clinical follow-up of 31.3 months (range, 12-54 months). Visual deficits attributable to progression were noted in 3 (12.5%) patients with pre-GKRS visual field defects. An additional 4 (16.7%) patients with pre-GKRS visual deficit developed new minor visual field defects. Four (16.7%) patients showed improvement of vision after GKRS. There were no new-onset post-GKRS hormonal deficits.
The management of craniopharyngioma requires a multidisciplinary approach, and irradiation represents effective treatment option for residual/recurrent tumors after surgery. To the best of our knowledge, this is the first study that addresses the efficacy of frameless hfGKRS in managing craniopharyngiomas over sufficient follow-up.
颅咽管瘤的治疗具有挑战性,通常需要多学科的综合治疗。伽玛刀放射外科(GKRS)是治疗颅咽管瘤残留/复发的重要手段。
评估无框架分次伽玛刀(hfGKRS)治疗颅咽管瘤的疗效,以及影响肿瘤控制和并发症的因素。
本回顾性研究纳入了 24 例接受 hfGKRS 治疗的患者。分析了临床和影像学资料、肿瘤特征和治疗过程的细节。
患者中 15 例(62.5%)为女性,中位年龄为 38.5 岁(范围 3-66 岁)。肿瘤平均体积为 2.4(1.93)cm 3 ,实性体积平均为 1.6(1.75)cm 3 。中位边缘剂量为 20 Gy(范围 18-25 Gy),中位分割次数为 5 次(范围 3-5 次)。在中位 23.5 个月(范围 12-50 个月)的影像学随访中,5 例(20.8%)患者肿瘤进展。2 年和 4 年无进展生存率分别为 81.8%和 61.4%。在中位 31.3 个月(范围 12-54 个月)的临床随访中未发现死亡病例。在有 GKRS 前视野缺损的 3 例(12.5%)患者中,出现了与进展相关的视力减退。另有 4 例(16.7%)GKRS 前有视力缺损的患者出现新的轻微视野缺损。4 例(16.7%)患者在 GKRS 后视力改善。没有新出现的激素缺乏症。
颅咽管瘤的治疗需要多学科综合治疗,放疗是手术切除后治疗残留/复发性肿瘤的有效方法。据我们所知,这是第一项在足够的随访中探讨无框架分次 hfGKRS 治疗颅咽管瘤疗效的研究。